Phenotypic and Genetic Correlates of Diabetes (Non-Type 1) in Young Non-Obese Asian Indians in North India and A Pilot Case Control Study to Evaluate the Efficacy of Sitagliptin (DPP-4 Inhibitor) in a Sub-group of the Study Population.
Phase of Trial: Phase IV
Latest Information Update: 10 Aug 2015
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacogenomic; Therapeutic Use
- 05 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 04 Feb 2014 Planned End Date changed from 1 May 2013 to 1 May 2014 as reported by ClinicalTrial .gov
- 26 May 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.